Equities

Alpha Teknova Inc

TKNO:NMQ

Alpha Teknova Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)6.38
  • Today's Change-1.18 / -15.61%
  • Shares traded467.93k
  • 1 Year change+227.18%
  • Beta0.3879
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.

  • Revenue in USD (TTM)34.94m
  • Net income in USD-34.27m
  • Incorporated2019
  • Employees210.00
  • Location
    Alpha Teknova Inc2451 Bert DriveHOLLISTER 95023United StatesUSA
  • Phone+1 (831) 637-1100
  • Fax+1 (845) 818-3588
  • Websitehttps://www.teknova.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zynex Inc193.67m4.82m296.16m1.10k62.808.4131.671.530.14810.14815.911.111.402.577.05176,059.103.4814.584.0617.5280.2079.622.4910.443.154.150.6246--16.5442.01-42.910.37412.19--
Pulmonx Corp79.30m-57.11m298.13m279.00--3.17--3.76-1.47-1.472.042.380.451.247.29284,236.60-32.41-26.27-36.42-28.9774.1671.95-72.01-93.766.77--0.2839--27.9827.98-3.26--20.62--
AngioDynamics, Inc.292.73m-243.03m302.32m748.00--1.55--1.03-6.04-6.047.254.790.74342.276.55391,344.90-61.72-16.38-74.39-18.7051.7152.95-83.02-30.491.41--0.00---10.282.35-251.53--13.09--
LifeMD Inc178.28m-26.60m305.79m207.00------1.72-0.7004-0.70044.70-0.1013.596.8638.19861,255.40-44.31-153.05-333.96-526.9188.9283.66-12.34-45.440.8327-8.191.13--28.1578.9051.27--143.64--
Clearpoint Neuro Inc30.43m-18.15m314.74m107.00--10.85--10.34-0.6912-0.69121.161.050.72421.509.66284,383.20-43.19-34.75-51.20-39.6760.3864.75-59.64-76.913.61--0.00--16.5626.64-34.40--75.30--
OraSure Technologies, Inc.224.26m11.37m316.28m638.0028.160.743212.921.410.15060.15063.015.710.48622.645.58351,509.402.720.72382.940.821242.2646.945.591.1311.20--0.00040.004.6417.41413.1782.2010.18--
Delcath Systems Inc11.88m-56.33m318.46m76.00--66.36--26.81-2.55-2.550.5050.15010.43220.61986.17156,289.50-204.97-116.57-356.98-243.2177.0571.02-474.22-1,235.372.04-54.370.5172---24.05-9.53-30.60---5.26--
Cerus Corp197.91m-19.73m377.00m288.00--7.04--1.90-0.1076-0.10761.080.28821.001.977.88687,194.40-10.01-25.99-15.26-40.6260.5261.90-10.00-35.811.92-1.190.6057---0.806119.6912.37--32.07--
MaxCyte Inc45.60m-35.74m377.63m143.00--1.77--8.28-0.3420-0.34200.43682.030.1770.55767.17318,878.30-13.87-13.18-14.86-14.3385.9888.79-78.37-62.969.22--0.00---6.7219.89-60.89--39.13--
Semler Scientific Inc58.94m15.91m378.86m92.0025.444.3522.896.432.052.057.5811.990.686817.209.33640,619.6018.5438.8320.3744.4188.0590.2227.0032.583.09--0.00--20.2825.9843.6932.64-0.3821--
Tactile Systems Technology Inc285.05m15.45m382.99m992.0024.821.8417.291.340.6430.64311.918.660.98126.206.80287,349.805.320.90156.201.0951.4449.105.420.83093.80--0.11460.0011.2013.81259.6033.91-23.62--
CVRx Inc47.26m-58.48m384.09m200.00--5.88--8.13-2.71-2.712.192.690.40380.6576.14236,275.00-49.96---54.21--84.16---123.75--10.23-17.040.4302--74.89--0.5528------
ZimVie Inc451.30m-47.73m393.84m2.60k--0.9681--0.8727-1.77-13.1616.6014.740.3941.144.04173,575.00-4.17---4.81--63.1865.51-10.58-8.731.38-0.62640.3514---1.26-16.08-19.50---23.70--
Alpha Teknova Inc34.94m-34.27m402.97m210.00--3.92--11.53-0.9295-0.92950.91671.930.28192.366.84166,381.00-27.65---32.36--22.38---98.08--3.28-29.500.144---11.43--22.52------
Nano-X Imaging Ltd10.13m-57.47m428.78m164.00--2.45--42.34-0.9974-0.99740.17552.990.0482--6.8961,756.10-27.33-30.98-29.96-35.10-81.80---567.41-1,527.245.09--0.0181--15.47--46.33--114.35--
Treace Medical Concepts Inc202.86m-61.52m516.44m516.00--4.92--2.55-0.9924-0.99243.271.680.89511.088.25393,141.50-27.15---32.22--80.61---30.33--2.98--0.3366--31.92---15.68------
Data as of Nov 12 2024. Currency figures normalised to Alpha Teknova Inc's reporting currency: US Dollar USD

Institutional shareholders

9.64%Per cent of shares held by top holders
HolderShares% Held
Millennium Management LLCas of 30 Jun 20241.85m3.46%
Balyasny Asset Management LPas of 30 Jun 20241.05m1.96%
The Vanguard Group, Inc.as of 30 Jun 2024550.12k1.03%
Roubaix Capital LLCas of 30 Sep 2024416.42k0.78%
Conestoga Capital Advisors LLCas of 30 Sep 2024305.13k0.57%
Parkman Healthcare Partners LLCas of 30 Jun 2024296.65k0.56%
Bank of America, NA (Private Banking)as of 30 Jun 2024216.38k0.41%
Osterweis Capital Management, Inc.as of 30 Jun 2024155.17k0.29%
Redmile Group LLCas of 30 Jun 2024154.51k0.29%
Geode Capital Management LLCas of 30 Jun 2024151.26k0.28%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.